| Drug common name | Gisadenafil |
| INN | gisadenafil |
| Description | Gisadenafil is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target cGMP-specific 3',5'-cyclic phosphodiesterase. |
| Classification | Small molecule |
| Drug class | phosphodiesterase type 5 inhibitors (PDE5) inhibitors: (PDE5) inhibitors containing a sulfonamide moiety |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | CCOc1ncc(S(=O)(=O)N2CCN(CC)CC2)cc1-c1nc2c(CC)n(CCOC)nc2c(=O)[nH]1 |
| PDB | — |
| CAS-ID | 334826-98-1 |
| RxCUI | — |
| ChEMBL ID | CHEMBL1928262 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | DB11902 |
| UNII ID | S6G4R7DI1C (ChemIDplus, GSRS) |
